RXi Pharmaceuticals (RXII -26%) tanks after announcing it plans to split into two publicly...
RXi Pharmaceuticals (RXII -26%) tanks after announcing it plans to split into two publicly traded companies later this year, separating its oncology and gene therapy businesses.
From other sites
at CNBC.com (May 21, 2014)
at CNBC.com (Apr 8, 2014)
at CNBC.com (Mar 17, 2014)
Video at CNBC.com (Jan 16, 2014)
at CNBC.com (Jan 16, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs